Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kane Biotech Inc (KNE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3411
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company serves industrial, human and animal healthcare industries. It conducts research and development programs through its on-site CL2 biofilm research laboratory in Canada. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc (KNE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Equity Offering 13
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Debt Offering 23
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc – Key Competitors 24
Kane Biotech Inc – Key Employees 25
Kane Biotech Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 21, 2018: Kane Biotech announces second quarter 2018 financial results 27
May 17, 2018: Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements 29
Mar 21, 2018: Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update 30
Nov 14, 2017: Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options 32
Aug 16, 2017: Kane Biotech – Q2 2017 Financial Results 33
May 17, 2017: Kane Biotech – Q1 2017 Financial Reports 34
Corporate Communications 35
May 22, 2018: Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors 35
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 36
Legal and Regulatory 37
Feb 26, 2018: Kane Biotech Sues Nestle 37
Other Significant Developments 38
Aug 09, 2018: Kane Biotech retains strategic expert in securing non-dilutive funding opportunities in the United States 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Kane Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc, Key Competitors 24
Kane Biotech Inc, Key Employees 25

List of Figures
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Torchlight Energy Resources Inc (TRCH):企業の財務・戦略的SWOT分析
    Summary Torchlight Energy Resources Inc (Torchlight Energy), formerly Known as Pole Perfect Studios Inc, is an oil and gas exploration and production company. The company’s activities include acquisition, exploration and development of domestic oil fields. Its business process includes investment ev …
  • Cytodyn Inc (CYDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies t for the treatment of Human Immunodeficiency Virus (HIV) infections. The company's products pipeline include PRO 140, Cytofe …
  • Dairy Crest Group plc:戦略・SWOT・企業財務分析
    Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report Summary Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Banque Cramer & Cie SA:企業の戦略・SWOT・財務情報
    Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report Summary Banque Cramer & Cie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • XL Group Ltd:戦略・SWOT・企業財務分析
    XL Group Ltd - Strategy, SWOT and Corporate Finance Report Summary XL Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報
    Summary MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prost …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • OMV AG:企業の戦略・SWOT・財務情報
    OMV AG - Strategy, SWOT and Corporate Finance Report Summary OMV AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • OMV AG (OMV):企業の戦略的SWOT分析
    OMV AG (OMV) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OS …
  • KUBOTA Corporation:企業の戦略・SWOT・財務情報
    KUBOTA Corporation - Strategy, SWOT and Corporate Finance Report Summary KUBOTA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KitCheck Inc:医療機器:M&Aディール及び事業提携情報
    Summary KitCheck Inc (KitCheck) is a provider of automated hospital pharmacy kit processing and medication tracking software solution. The company’s Kit Check is an automated medication tray management system based on scalable cloud software platform uses RFID tags to track each medication that help …
  • Pon Holdings BV:企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Insurance and Care NSW:企業の戦略的SWOT分析
    Insurance and Care NSW - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SANUWAVE Health Inc (SNWV):企業の財務・戦略的SWOT分析
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆